Express Pharma - Page 318 of 2181 - Express Pharma

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

Leading people in the age of AI

Glenmark Pharma gets ANDA nod for Apremilast Tablets, 10 mg, 20 mg and 30 mg

Granules India, NIPER sign MoU to Dr Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical Development

Nidlegy Phase III PIVOTAL trial shows postive results for patients with locally advanced fully resectable melanoma

Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines

Zydus appoints Punit Patel as President and CEO, Americas

India-Japan collaborations in the nutraceuticals space

Lupin gets tentative nod from US FDA for apalutamide tablets

SGD Pharma expands Sterinity range of RTU Type I molded glass vials

Flawless Pharma signs API deals with European CDMO and African company for $120 million

CEQUA phase 4 data shows sustained improvement in dry eye disease signs and symptoms